 |
|
|
|
|
|
 Title: |
EP0068047A2:
Enriched plasma derivative for promoting wound sealing and wound healing[German][French]
[ Derwent Title ]
|
Country:
Kind: |
EP European Patent Office (EPO)
A2 APPLICATION PUBLISHED WITHOUT SEARCH REPORT i
(See also:
EP0068047A3,
EP0068047B1 )
|
| |
| Inventor: |
Serapharm - Michael Stroetmann;
|
| Assignee: |
Serapharm - Michael Stroetmann
News, Profiles, Stocks and More about this company
|
| Published / Filed: |
1983-01-05
/ 1981-12-18
|
| Application Number: |
EP1981000110615
|
| IPC Code: |
Advanced:
A61K 31/43;
A61K 35/14;
A61K 35/30;
A61K 38/00;
A61K 38/16;
A61K 38/17;
A61K 38/36;
A61K 38/48;
A61K 38/55;
A61L 15/44;
A61L 15/64;
A61L 24/10;
A61L 26/00;
A61L 27/00;
A61L 27/22;
A61F 2/00;
Core:
A61K 31/429;
A61K 38/43;
A61L 15/16;
A61L 24/00;
more...
IPC-7:
A61K 35/16;
A61K 37/02;
A61K 37/475;
A61K 37/54;
A61K 37/62;
A61L 15/03;
A61L 15/04;
A61L 17/00;
|
| ECLA Code: |
A61K35/14; A61K38/00A; A61K38/36A; A61K38/48K5; A61K38/48K5+M; A61L24/10A; A61L24/10F; A61L24/10R; A61L26/00B6A; A61L26/00B6F; A61L26/00F; A61L26/00H2; A61L27/22F; K61F2/00A66F;
|
| Priority Number: |
| 1981-06-25 |
DE1981003124962 |
| 1981-12-18 |
EP1981000110615 |
|
| Abstract: |
[From equivalent
EP0068047A3]
SDOAB
Enriched plasma deriv. (A) comprises components exclusively in powdered form and its compsn. is chosen with regard (a) to optimal activation of exogenous and/or endogenous blood coagulation systems and (b) to a number of physiological and opt. pathological considerations. The major components are fibrinogen (I), thrombin (II), components of the prothrombin (III) complex and protease inhibitors. It may also contain thrombocyte extracts, antibiotics, etc. A pref. formulation contains 60-96 wt.% (I), practically free of water-insoluble globulins (content pref. below 2 wt.%); 0.05-5 wt.% fibrinolysis inhibitors; 0.1-15 wt.% (II) and/or (III). All components are in solid, powdered forms and are simply mixed together. (A) is a biochemical substrate for accelerating haemostasis and optimal regulation of wound closure. It has an almost unlimited storage life at room temp. without agglomeration; can be used directly without any additives, and is quickly soluble in body fluids.
[German]
|
| INPADOC Legal Status: |
Show legal status actions
Family Legal Status Report
|
| Designated Country: |
SE
|
| Family: |
Show 22 known family members
|
